BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25015864)

  • 1. Abnormal cervical cytology after allogeneic bone marrow transplantation.
    Negri G; Herz M; Deola S; Piccin A; Casini M; Babich B; Tauber M; Messini S; Marucci MR; Vittadello F
    Am J Clin Pathol; 2014 Aug; 142(2):222-6. PubMed ID: 25015864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
    Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical cytological changes mimicking SIL of the uterine cervix in allogenic hematopoietic stem cell transplantation recipients treated with busulfan.
    Saco A; Alòs S; Esteve R; Suárez-Lledó M; Martínez C; Perez FM; Vega N; Martí C; Torne A; Ordi J; Del Pino M
    Cancer Cytopathol; 2019 Jun; 127(6):399-406. PubMed ID: 31145550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.
    Khumthong K; Aue-Aungkul A; Kleebkaow P; Chumworathayi B; Temtanakitpaisan A; Nhokaew W
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2847-2850. PubMed ID: 31554386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
    Alanen KW; Elit LM; Molinaro PA; McLachlin CM
    Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women.
    Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
    Cancer; 2001 Feb; 93(1):1-7. PubMed ID: 11241259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between the cervico-vaginal inflammatory cytology and the intraepithelial cervical lesion in patients from a sexual and reproductive health clinic in Bogotá, Colombia, 1999-2003].
    Duarte HG; Romero JA; Schmalbach JE
    Rev Salud Publica (Bogota); 2004; 6(3):253-69. PubMed ID: 15656066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cervix smears with mild atypia classified as Pap-class IIIA: results of a changed policy].
    Doornewaard H; Woudt JM; Sie-Go DM; Kooijman CD
    Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1642-5. PubMed ID: 1922503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
    Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
    Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The postpartum Papanicolaou smear.
    Weiss BD; Senf JH; Udall W
    J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with atypical and low-grade Pap smear abnormalities.
    Nuovo J; Melnikow J; Paliescheskey M
    Am Fam Physician; 1995 Dec; 52(8):2243-50. PubMed ID: 7484718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DNA cytometry of postirradiation cervicovaginal smears.
    Davey DD; Zaleski S; Sattich M; Gallion H
    Cancer; 1998 Feb; 84(1):11-6. PubMed ID: 9500647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of abnormal Papanicolaou smears among women of different races.
    Carey P; Gjerdingen DK
    J Fam Pract; 1993 Dec; 37(6):583-7. PubMed ID: 8245810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal Pap smears with negative follow-up biopsies: improving cytohistologic correlations.
    Bewtra C; Pathan M; Hashish H
    Diagn Cytopathol; 2003 Oct; 29(4):200-2. PubMed ID: 14506671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.